AKTIS ONCOLOGY
HQ - Boston, Massachusetts
Summary
Aktis Oncology, a biotechnology company discovering and developing novel targeted radiopharmaceuticals to treat a broad range of solid tumors.
Deals Overview
Total Deals2
Valued Deals1
Total Value£ 131 M
Avg. Deal Size£ 131 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
